Maenner MJ, Warren Z, Williams AR, Amoakohene E, Bakian AV, Bilder DA, Durkin MS, Fitzgerald RT et al (2023) Prevalence and Characteristics of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 Sites, United States, 2020. MMWR Surveill Summ (Washington, D.C. : 2002). 72:1–14. https://doi.org/10.15585/mmwr.ss7202a1

Zhou H, Xu X, Yan W, Zou X, Wu L, Luo X, Li T, Huang Y et al (2020) Prevalence of autism spectrum disorder in China: a nationwide multi-center population-based study among children aged 6 to 12 years. Neurosci Bull 36:961–971. https://doi.org/10.1007/s12264-020-00530-6

Article  PubMed  PubMed Central  Google Scholar 

Morella IM, Brambilla R, Morè L (2022) Emerging roles of brain metabolism in cognitive impairment and neuropsychiatric disorders. Neurosci Biobehav Rev 142:104892. https://doi.org/10.1016/j.neubiorev.2022.104892

Article  CAS  PubMed  Google Scholar 

Zawadzka A, Cieślik M, Adamczyk A (2021) The role of maternal immune activation in the pathogenesis of autism: a review of the evidence, proposed mechanisms and implications for treatment. Int J Mol Sci 22:11516. https://doi.org/10.3390/ijms222111516

Article  CAS  PubMed  PubMed Central  Google Scholar 

Simone JJ, Green MR, McCormick CM (2022) Endocannabinoid system contributions to sex-specific adolescent neurodevelopment. Prog Neuropsychopharmacol Biol Psychiatry 113:110438. https://doi.org/10.1016/j.pnpbp.2021.110438

Article  CAS  PubMed  Google Scholar 

Brigida AL, Schultz S, Cascone M, Antonucci N, Siniscalco D (2017) Endocannabinod signal dysregulation in autism spectrum disorders: a correlation link between inflammatory state and neuro-immune alterations. Int J Mol Sci 18. https://doi.org/10.3390/ijms18071425

Busquets-García A, Bolaños JP, Marsicano G (2022) Metabolic messengers: endocannabinoids. Nat Metab 4:848–855. https://doi.org/10.1038/s42255-022-00600-1

Article  PubMed  Google Scholar 

Psychoyos D, Vinod KY, Cao J, Xie S, Hyson RL, Wlodarczyk B, He W, Cooper TB et al (2012) Cannabinoid receptor 1 signaling in embryo neurodevelopment. Birth defects research. Part B Dev Rep Toxicol 95:137–150. https://doi.org/10.1002/bdrb.20348

Article  CAS  Google Scholar 

Oudin MJ, Gajendra S, Williams G, Hobbs C, Lalli G, Doherty P (2011) Endocannabinoids regulate the migration of subventricular zone-derived neuroblasts in the postnatal brain. J Neurosci Official J Society Neurosci 31:4000–4011. https://doi.org/10.1523/jneurosci.5483-10.2011

Article  CAS  Google Scholar 

Ruiz-Contreras HA, Santamaría A, Arellano-Mendoza MG, Sánchez-Chapul L, Robles-Bañuelos B, Rangel-López E (2022) Modulatory activity of the endocannabinoid system in the development and proliferation of cells in the CNS. Neurotox Res 40:1690–1706. https://doi.org/10.1007/s12640-022-00592-6

Article  CAS  PubMed  Google Scholar 

Soltys J, Yushak M, Mao-Draayer Y (2010) Regulation of neural progenitor cell fate by anandamide. Biochem Biophys Res Commun 400:21–26. https://doi.org/10.1016/j.bbrc.2010.07.129

Article  CAS  PubMed  Google Scholar 

Xapelli S, Agasse F, Sardà-Arroyo L, Bernardino L, Santos T, Ribeiro FF, Valero J, Bragança J et al (2013) Activation of type 1 cannabinoid receptor (CB1R) promotes neurogenesis in murine subventricular zone cell cultures. PLoS ONE 8:e63529. https://doi.org/10.1371/journal.pone.0063529

Article  PubMed  PubMed Central  Google Scholar 

Pietropaolo S, Marsicano G (2022) The role of the endocannabinoid system as a therapeutic target for autism spectrum disorder: Lessons from behavioral studies on mouse models. Neurosci Biobehav Rev 132:664–678. https://doi.org/10.1016/j.neubiorev.2021.11.031

Article  PubMed  Google Scholar 

Zou M, Liu Y, Xie S, Wang L, Li D, Li L, Wang F, Zhang Y et al (2021) Alterations of the endocannabinoid system and its therapeutic potential in autism spectrum disorder. Open Biol 11:200306. https://doi.org/10.1098/rsob.200306

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aran A, Eylon M, Harel M, Polianski L, Nemirovski A, Tepper S, Schnapp A, Cassuto H et al (2019) Lower circulating endocannabinoid levels in children with autism spectrum disorder. Mol Autism 10:2. https://doi.org/10.1186/s13229-019-0256-6

Article  PubMed  PubMed Central  Google Scholar 

Salcedo-Arellano MJ, Cabal-Herrera AM, Punatar RH, Clark CJ, Romney CA, Hagerman RJ (2021) Overlapping Molecular pathways leading to autism spectrum disorders, fragile X syndrome, and targeted treatments. Neurotherapeutics 18:265–283. https://doi.org/10.1007/s13311-020-00968-6

Article  CAS  PubMed  Google Scholar 

Dias-de Freitas F, Pimenta S, Soares S, Gonzaga D, Vaz-Matos I, Prior C (2022) The role of cannabinoids in neurodevelopmental disorders of children and adolescents. Revista de neurologia. 75:189–197. https://doi.org/10.33588/rn.7507.2022123

Article  CAS  PubMed  Google Scholar 

Carbone E, Manduca A, Cacchione C, Vicari S, Trezza V (2021) Healing autism spectrum disorder with cannabinoids: a neuroinflammatory story. Neurosci Biobehav Rev 121:128–143. https://doi.org/10.1016/j.neubiorev.2020.12.009

Article  CAS  PubMed  Google Scholar 

Pedrazzi JFC, Ferreira FR, Silva-Amaral D, Lima DA, Hallak JEC, Zuardi AW, Del-Bel EA, Guimarães FS et al (2022) Cannabidiol for the treatment of autism spectrum disorder: hope or hype? Psychopharmacology 239:2713–2734. https://doi.org/10.1007/s00213-022-06196-4

Article  CAS  PubMed  Google Scholar 

Fyke W, Alarcon JM, Velinov M, Chadman KK (2021) Pharmacological inhibition of the primary endocannabinoid producing enzyme, DGL-α, induces autism spectrum disorder-like and co-morbid phenotypes in adult C57BL/J mice. Autism Res 14:1375–1389. https://doi.org/10.1002/aur.2520

Article  PubMed  Google Scholar 

Manduca A, Lassalle O, Sepers M, Campolongo P, Cuomo V, Marsicano G, Kieffer B, Vanderschuren LJ et al (2016) Interacting cannabinoid and opioid receptors in the nucleus accumbens core control adolescent social play. Front Behav Neurosci 10:211. https://doi.org/10.3389/fnbeh.2016.00211

Article  CAS  PubMed  PubMed Central  Google Scholar 

Folkes OM, Báldi R, Kondev V, Marcus DJ, Hartley ND, Turner BD, Ayers JK, Baechle JJ et al (2020) An endocannabinoid-regulated basolateral amygdala-nucleus accumbens circuit modulates sociability. J Clin Investig 130:1728–1742. https://doi.org/10.1172/jci131752

Article  CAS  PubMed  PubMed Central  Google Scholar 

Seillier A, Giuffrida A (2018) The cannabinoid transporter inhibitor OMDM-2 reduces social interaction: further evidence for transporter-mediated endocannabinoid release. Neuropharmacology 130:1–9. https://doi.org/10.1016/j.neuropharm.2017.11.032

Article  CAS  PubMed  Google Scholar 

Manduca A, Servadio M, Campolongo P, Palmery M, Trabace L, Vanderschuren LJ, Cuomo V, Trezza V (2014) Strain- and context-dependent effects of the anandamide hydrolysis inhibitor URB597 on social behavior in rats. Eur Neuropsychopharmacol J European College Neuropsychopharmacol 24:1337–1348. https://doi.org/10.1016/j.euroneuro.2014.05.009

Article  CAS  Google Scholar 

Trezza V, Damsteegt R, Manduca A, Petrosino S, Van Kerkhof LW, Pasterkamp RJ, Zhou Y, Campolongo P et al (2012) Endocannabinoids in amygdala and nucleus accumbens mediate social play reward in adolescent rats. J Neurosci 32:14899–14908. https://doi.org/10.1523/JNEUROSCI.0114-12.2012

Article  CAS  PubMed  PubMed Central  Google Scholar 

Seillier A, Advani T, Cassano T, Hensler JG, Giuffrida A (2010) Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats. Int J Neuropsychopharmacol 13:373–386. https://doi.org/10.1017/s146114570999023x

Article  CAS  PubMed  Google Scholar 

Wei D, Dinh D, Lee D, Li D, Anguren A, Moreno-Sanz G, Gall CM, Piomelli D (2016) Enhancement of anandamide-mediated endocannabinoid signaling corrects autism-related social impairment. Cannabis Cannabinoid Res 1:81–89. https://doi.org/10.1089/can.2015.0008

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu HF, Lu TY, Chu MC, Chen PS, Lee CW, Lin HC (2020) Targeting the inhibition of fatty acid amide hydrolase ameliorate the endocannabinoid-mediated synaptic dysfunction in a valproic acid-induced rat model of Autism. Neuropharmacology 162:107736. https://doi.org/10.1016/j.neuropharm.2019.107736

Article  CAS  PubMed